Purdue research identifies new risk factor for drug-induced QT interval prolongation

Wednesday, April 16, 2025 | Steve Martin   WEST LAFAYETTE, Ind. — Purdue University researchers are developing innovative antibody-based immunotherapies that recruit and improve the function of the body’s innate immune system to treat glioblastoma, an incurable...

The American Association of Colleges of Pharmacy today announced the recipients of its top awards for 2025

Tuesday, March 4, 2025 A Purdue University College of Pharmacy Researcher has found a way to manufacture important chemical structures required as catalysts to help form chemical structures that can stabilize certain medications in a more controlled manner. Severin...